Parotitis and Orchitis Cases due to Measles-Mumps-Rubella Vaccine

被引：1
|
作者：
Sultanova, Fidan [1 ]
Ozger, Hasan Selcuk [1 ]
Ozer, Fatma [1 ]
Yildiz, Yesim [1 ]
Senol, Esin [1 ]
机构：
[1] Gazi Univ, Tip Fak, Infeks Hastaliklari & Klin Mikrobiyol Anabilim, Ankara, Turkey
来源：
KLIMIK JOURNAL | 2022年 / 35卷 / 01期
关键词：
mumps; MMR vaccine; Parotitis; Orchitis; Vaccine Adverse Events;
D O I：
10.36519/kd.2022.3922
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Although it is known that parotitis and orchitis cases may develop due to mumps strain included in the MMR vaccine, it has been shown that vaccines containing L-Z mumps strains may be associated with these side effects more frequently. In this article, we evaluated vaccine-related parotitis and orchitis cases in healthcare workers after measles-mumps -ru-bella (MMR) vaccine containing Edmonston-Zagreb measles, Leningrad-Zagreb mumps and Wistar Ra 27/3 measles strains. Twelve mumps seronegative healthcare workers developed parotitis and orchitis after the MMR vaccine con-taining L-Z mumps strain. The cases were confirmed serologically with mumps IgM positivity
引用
收藏
页码：46 / 48
页数：3
相关论文
共 50 条
  • [21] Science vs "scaremongering" over measles-mumps-rubella vaccine
    Wise, J
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2001, 79 (03) : 272 - 272
  • [22] Measles-Mumps-Rubella Vaccine and COVID-19 Relationship
    Ozdemir, Oner
    MBIO, 2020, 11 (05):
  • [23] Pityriasis lichenoides triggered by measles-mumps-rubella vaccine injection
    Filippi, Federica
    Patrizi, Annalisa
    Sabattini, Elena
    Varotti, Elisa
    Bertuzzi, Clara
    Pileri, Alessandro
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 (07): : 758 - 760
  • [24] CLINICAL EVALUATION OF A NEW MEASLES-MUMPS-RUBELLA TRIVALENT VACCINE
    SCHWARZ, AJF
    JACKSON, JE
    EHRENKRANZ, NJ
    VENTURA, A
    SCHIFF, GM
    WALTERS, VW
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1975, 129 (12): : 1408 - 1412
  • [25] SYSTEMIC REACTIONS TO MEASLES-MUMPS-RUBELLA VACCINE SKIN TESTING
    PUVVADA, L
    SILVERMAN, B
    BASSETT, C
    CHIARAMONTE, LT
    PEDIATRICS, 1993, 91 (04) : 835 - 836
  • [26] BENEFITS, RISKS, AND COSTS OF IMMUNIZATION WITH MEASLES-MUMPS-RUBELLA VACCINE
    WHITE, CC
    KOPLAN, JP
    ORENSTEIN, WA
    MEDICAL DECISION MAKING, 1983, 3 (03) : 353 - 353
  • [27] Persistence of Rubella Antibodies after 2 Doses of Measles-Mumps-Rubella Vaccine
    LeBaron, Charles W.
    Forghani, Bagher
    Matter, Lukas
    Reef, Susan E.
    Beck, Carol
    Bi, Daoling
    Cossen, Cynthia
    Sullivan, Bradley J.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (06): : 888 - 899
  • [28] Has the measles-mumps-rubella vaccine been fully exonerated?
    Katz, Samuel L.
    PEDIATRICS, 2006, 118 (04) : 1744 - 1745
  • [29] Age for routine administration of the second dose of measles-mumps-rubella vaccine
    Halsey, NA
    Abramson, JS
    Chesney, PJ
    Fisher, MC
    Gerber, MA
    Gromisch, DS
    Kohl, S
    Marcy, SM
    Murray, DL
    Overturf, GD
    Whitley, RJ
    Yogev, R
    Peter, G
    Hall, CB
    Schwartz, B
    Breiman, R
    Hardegree, MC
    Jacobs, RF
    MacDonald, NE
    Orenstein, WA
    Rabinovich, NR
    PEDIATRICS, 1998, 101 (01) : 129 - 133
  • [30] Response to measles-mumps-rubella vaccine in children with autistic spectrum disorders
    Gentile, Ivan
    Borgia, Guglielmo
    Zappulo, Emanuela
    Settimi, Alessandro
    Lanzara, Valentina
    Sperandeo, Serena
    Riccio, Maria Pia
    Bravaccio, Carmela
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S215 - S215
12345